← Eichor
Condition: Plasma Multi Omics Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Plasma Multi Omics

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07214324
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
Phase N/A · 1 location(s) · Beijing Anzhen Hospital · NCT06885619
Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation
Phase N/A · 1 location(s) · Central China Fuwai Hospital of Zhengzhou University · NCT07113769
Feasibility of a Multi-omics Platform for Hematological Malignancies
NA · 1 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT07445438
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TU
NA · 2 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT07403630
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.